MetaTrader
  • Marchés
  • Graphique & Idées
  • Algo
  • Nouvelles
  • Store
  • Courtiers
  • Télécharger
  • Calendrier Economique
  • Signaux de trading
  • Terminal Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • Deutsch Deutsch
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Lantern Pharma Inc. Common Stock

LTRN

#3633
Lantern Pharma Inc. Common Stock
2.8200
-2.08%
Secteur:
Base:
Devise de Profit:
Range quotidien
2.8200
2.8200
Range Annuel
2.4500
4.2800
Changement quotidien
-2.08%
Changement Mensuel
-13.23%
Evolution sur 6 mois
-32.70%
Changement Annuel
-32.70%
Clôture Précédente
2.8800
Open
2.8200
Bid
Ask
Low
2.8200
High
2.8200
Volume
1
  1. Marchés
  2. Actions des Marchés US
  3. Soins de Santé
  4. LTRN
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25 TTM

Nouvelles

Investing Investing
LTRN
2026.01.20
랜턴 파마, 희귀의약품으로 지정 (LP-284, 육종 치료제)
Investing Investing
LTRN
2026.01.20
FDA grants orphan drug designation to Lantern Pharma’s LP-284 for sarcomas
Investing Investing
LTRN
2025.12.03
Lantern, 암 치료제 LP-184, 1a상 시험서 유망 결과
Investing Investing
LTRN
2025.12.03
Lantern’s cancer drug LP-184 shows promise in phase 1a trial
Seeking Alpha Seeking Alpha
LTRN
2025.11.21
Lantern Pharma Inc. (LTRN) Discusses LP-184 Phase 1a Clinical Results and Implications for DNA Damage Repair-Deficient Tumors Transcript
Seeking Alpha Seeking Alpha
LTRN
2025.11.15
Lantern Pharma Inc. 2025 Q3 - Results - Earnings Call Presentation (NASDAQ:LTRN) 2025-11-15
Seeking Alpha Seeking Alpha
LTRN
2025.11.13
Lantern Pharma Inc. (LTRN) Q3 2025 Earnings Call Transcript
Investing Investing
DIS PRSO AMAT BLDP BWEN
2025.11.12
Disney, Brookfield, Nu Holdings and more set to report earnings Thursday
Investing Investing
LTRN
2025.09.23
Lantern Pharma, 이사진 선출 및 스톡옵션 가격 재조정 승인
Investing Investing
LTRN
2025.09.23
Lantern Pharma shareholders elect directors and approve stock option repricing
Investing Investing
LTRN
2025.09.16
Lantern Pharma, LP-184 암 치료제 임상 성공에 주가 급등
Investing Investing
LTRN
2025.09.16
Lantern Pharma stock climbs after LP-184 cancer drug hits trial endpoints

Marchés

  • Actions
  • Devises
  • Crypto-monnaies
  • Métaux
  • Matières premières

Graphique & Idées

  • Idées de Trading
  • Idées de Formations
  • Graphiques

MQL5 Community

  • Marché
  • Signaux
  • Forum
  • Articles
  • CodeBase

Nouvelles

  • Actions
  • Devises
  • Crypto-monnaies
  • Métaux
  • Matières premières

Courtiers

  • Tous les Courtiers
  • Forex
  • Actions
  • Métaux
MetaTrader 5
MQL5 Channels
Economic Calendar
Clause de Non-Responsabilité et Divulgation des Risques Conditions d'Utilisation Contacts et Demandes Légal
Copyright 2000-2026, MetaQuotes Ltd